Polyembryoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180229C80.9
Who is this for?
Show terms as
5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Polyembryoma is an extremely rare type of germ cell tumor characterized by the presence of structures resembling early embryonic development, known as embryoid bodies. These embryoid bodies morphologically recapitulate stages of normal embryogenesis, containing structures that resemble the embryonic disc, yolk sac, and amniotic cavity. Polyembryoma most commonly arises in the gonads, particularly the ovaries and testes, though it can occasionally occur in extragonadal sites such as the mediastinum. It is classified among mixed germ cell tumors and is almost always found as a component within a mixed germ cell neoplasm rather than in pure form. Polyembryoma typically presents in adolescents and young adults. In ovarian cases, patients may present with an abdominal or pelvic mass, abdominal pain, or swelling. Serum tumor markers such as alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) may be elevated, reflecting the presence of yolk sac tumor and trophoblastic components within the embryoid bodies. In testicular cases, a painless testicular mass is the most common presentation. Due to its extreme rarity, there are no standardized treatment protocols specific to polyembryoma. Management generally follows guidelines for malignant germ cell tumors and typically involves surgical resection followed by platinum-based combination chemotherapy (such as BEP: bleomycin, etoposide, and cisplatin). Prognosis depends on the stage at diagnosis, the specific components of the mixed germ cell tumor, and the response to chemotherapy. Because pure polyembryoma is exceedingly rare, most clinical data are derived from case reports and small case series, making definitive prognostic statements difficult.

Clinical phenotype terms— hover any for plain English:

Gonadal neoplasmHP:0010785Neuroectodermal neoplasmHP:0030061Abnormal circulating gonadotropin concentrationHP:0030338Abnormal peritoneum morphologyHP:0002585Abnormal sacrum morphologyHP:0005107Elevated circulating alpha-fetoprotein concentrationHP:0006254Neoplasm of head and neckHP:0012288Abdominal massHP:0031500Abnormal onset of bleedingHP:0040231Abnormal mediastinum morphologyHP:0045026Abnormality of the endocrine systemHP:0000818Irregular menstruationHP:0000858Increased serum serotoninHP:0003144Isosexual precocious pubertyHP:0008236Increased serum testosterone levelHP:0030088
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Polyembryoma.

View clinical trials →

No actively recruiting trials found for Polyembryoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Polyembryoma community →

Specialists

5 foundView all specialists →
DM
Darren Feldman, MD
NEW YORK, NY
Specialist
PI on 8 active trials
LH
Lisa Hess
Specialist
PI on 1 active trial6 Polyembryoma publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Polyembryoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open PolyembryomaForum →

No community posts yet. Be the first to share your experience with Polyembryoma.

Start the conversation →

Latest news about Polyembryoma

No recent news articles for Polyembryoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Polyembryoma

What is Polyembryoma?

Polyembryoma is an extremely rare type of germ cell tumor characterized by the presence of structures resembling early embryonic development, known as embryoid bodies. These embryoid bodies morphologically recapitulate stages of normal embryogenesis, containing structures that resemble the embryonic disc, yolk sac, and amniotic cavity. Polyembryoma most commonly arises in the gonads, particularly the ovaries and testes, though it can occasionally occur in extragonadal sites such as the mediastinum. It is classified among mixed germ cell tumors and is almost always found as a component within a

How is Polyembryoma inherited?

Polyembryoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Polyembryoma?

5 specialists and care centers treating Polyembryoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.